Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramyometrial Ergometrine vs Carbetocin to Decrease Blood Loss During Abdominal Myomectomy
NCT07390864Recruiting
- Sponsor
- Cairo University
- Start
- Jan 2026
- Primary completion
- Jul 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of carbetocin in Uterine Fibroids (UF) (2 arms), sponsored by Cairo University. Primary endpoint: Estimated Intraoperative and Postoperative Blood Loss at 48 hours. Started Jan 2026; status: recruiting.
02
Drugs
carbetocin
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT07390864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07390864.